results in the lasting restoration of a patients' lymphoid system. 4, 5 As part of this study, we recently generated ADAdeficient mice via gene targeting in embryonic stem cells. Adenosine-deaminase-deficient mice were generated to investigate the role of adenosine deaminase (ADA) in
Adenosine-deaminase-deficient mice were generated to investigate the role of adenosine deaminase (ADA) in
In mice, however, absence of ADA induces hepatocellular impairment and perinatal lethality. 6, 7 Consequently, ADAlymphocyte maturation and to test treatment options for the severe combined immunodeficiency (SCID) associadeficient mice as such are inappropriate as an animal model of human ADA − SCID. Nevertheless, evidence exists that, ted with the absence of ADA in man. Whereas either genetic absence or postnatal inhibition of ADA affect in addition to a critical role in murine fetal development, in mice ADA is also needed postnatally for proper immune primarily the haematopoietic system in both humans and mice, ADA-deficient mice die in the perinatal perfunction. 6, [8] [9] [10] [11] In view of the fact that ADA-deficiency in humans as iod. Consequently, we haematopoietically reconstituted lethally irradiated wild-type recipient mice with ADAwell as mice postnatally is primarily a haematopoietic disorder, we investigated whether the engraftment of murine deficient fetal liver cells. Although the liver cells of gestational day 14 ADA-deficient murine embryos ADA-deficient haematopoietic cells into lethally irradiated wild-type animals would yield an animal model presenting appeared metabolically deranged, their in vivo and in vitro colony-forming capacities were similar to those of the clinical phenotype of human ADA − SCID. It is important in this respect that Ferrari et al 12 observed that wild-type embryos. Lethally irradiated wild-type mice transplanted with ADA-deficient fetal liver cells human ADA-deficient peripheral blood lymphocytes, in contrast to wild-type and human ADA gene-transduced appeared immunologically normal. Following mitogen stimulation, their splenocytes and thymocytes were ADA-deficient peripheral blood lymphocytes, failed to survive in immunodeficient mice. This suggested that it is more sensitive to deoxyadenosine than those from wildtype fetal liver chimaeras. This feature, characteristic advantageous to cells to express ADA, even in an environment where ADA is present. Because ADA-deficient mice of ADA-deficiency, indicated that mature and active lymphocytes were generated from ADA-deficient fetal die perinatally we isolated the fetal livers of 14-day-old embryos as a source of haematopoietic progenitor cells. liver cells following transplantation into wild-type hosts.
Because approximately 20% of the haematopoietic cells
Here we report that lethally irradiated mice which received an ADA-deficient fetal liver-cell transplant appeared recipient-derived, it can not be concluded that the murine haematopoietic system can do without ADAappeared immunologically normal. ADA-deficient fetal liver chimaeras generated mature and active ADA-deficient producing cells. Keywords: adenosine-deaminase deficiency; adenosine-T and B cells, probably due to detoxification of dAdo in the serum by endogenous tissues. deaminase-deficient mice or knockout mice; fetal liver cell transplantation; lymphocytes
Materials and methods
In ADA-deficient humans, toxic effects of the ADA substrates adenosine (Ado) and deoxyadenosine (dAdo) primarily interfere with lymphoid development, causing Histopathological analysis SCID. 1, 2 Despite the fact that the disease is rare (incidence 1 in 200 000-1 000 000 births 3 ) , it serves as a model in the ADA-heterozygous mice were mated. At day 14 of gesdevelopment of gene therapy for human inherited disorders.
tation (the day of a coital plug is scored as day 1) embryos It is envisaged that retransplantation of haematopoietic were removed from the uteri and fixed in 10% phosphatestem cells transduced with an intact human ADA cDNA buffered formalin. Tails were clipped for genotypic analysis. After processing to paraffin blocks, semi-serial sections stained with haematoxylin-phloxine-saffran were prepared.
Analysis of ADA-associated metabolic pathways
Southern blot analysis, genomic DNA was isolated from the peripheral blood leucocytes obtained after lysing the ADA+/− mice were mated. At day 14 of gestation embryos red blood cells in (0.83% NH 4 Cl, 0.1% NaHCO 3 , 80 m were removed from the uteri and fetal livers were stored EDTA). At 3, 4 and 13 months after FLT thymuses and individually in liquid N 2 . Tails were clipped for genotypic spleens were removed and collected in HBSS on ice. Sinanalysis. ADA, S-adenosylhomocysteine hydrolase gle-cell suspensions were prepared. Flow-cytometric analy-(AdoHcyase) and purine nucleoside phosphorylase (PNP) sis and mitogenic stimulation were performed as described activities as well as concentrations of free Ado and dAdo, below. In addition, cells were subjected to Southern blot adenine ribonucleotides (AMP+ADP+ATP) and deoxyrianalysis. bonucleotides (dAMP+dADP+dATP) were measured as described. 6 In total, three ADA−/−, three ADA+/− and three Zymogram analysis ADA+/+ animals were examined.
Preparation of lysates and zymogram analysis were as described. 16 Packed blood cells were sonicated in one volFetal liver-cell transplantation and spleen colony assay ume of lysis buffer. ADA+/− 129/Ola mice were mated and at days 14-15 of gestation, embryos were removed from the uteri. Fetal liv-DNA analysis ers were kept individually in Hank's balanced salt solution buffered at pH 7.2 with 10 mm Hepes buffer (HBSS) on Genomic DNA was prepared essentially as described.
17
ice. Single-cell suspensions, prepared by gently squeezing Southern blot analysis of EcoRI-digested genomic DNA the fetal livers through a nylon gauze sieve, were washed was performed according to standard procedures. 18 The with HBSS, and nucleated cells counted.
probes used were: a 3.0-kb HindIII genomic murine ADA Syngeneic (129/Ola) 10-25-week-old wild-type recipient fragment recognizing both the 11.0-kb and the 9.5-kb mice, equal numbers of males and females, were put on EcoRI fragments diagnostic for the wild-type and the water containing antibiotics (100 mg/l ciproxin 750 (Bayer, mutant ADA alleles, respectively, and pY 2 , pBR322 conLeverkusen, Germany), 100 mg/l polymycin B sulphate taining 720 bp of BALB/c Y chromosomal DNA. 19 Quantiu.s.p. (Pfizer, New York, USA), 200 mg/l delvocid (Gist tations were performed with a PhosphorImager device Brocades, Delft, The Netherlands), 50 g/l sucre) from 1 (Molecular Dynamics, Sunnyvale, CA, USA). week prior to 2 weeks after fetal liver-cell transplantation (FLT). Mice were housed under SPF conditions.
Flow-cytometric analysis For long-term repopulation, 10 7 cells in 0.5 ml HBSS were injected intravenously into recipient mice within [2] [3] [4] Two-colour immunofluorescence analysis was performed h after irradiation (9.5 Gy, using a ␥-ray source at a dose on peripheral blood leucocytes and single-cell suspensions rate of 0.65 Gy/min). Four irradiation controls received no of spleen and thymus as described. 6, 16 transplant. The spleen colony-forming capacity of the fetal liver cells was assayed by injecting 2 × 10 5 fetal liver cells Magnetic cell sorting of splenic B and T cells in 0.5 ml HBSS intravenously into irradiated recipient mice.
13,14 Twelve days post-transplantation, macroscopic At 13 months after FLT, the spleens of the fetal liver chicolonies on the spleen were counted and dissected for zymmaeras were isolated and single-cell suspensions made. ogram and DNA analysis.
Nucleated cells were counted and 3 × 10 6 cells were stored for genotypic analysis. To select splenic B cells, splenocytes were labelled with FITC-conjugated RA3-6B2 (antiIn vitro clonal progenitor cell assay B220). Magnetic separation with MACS anti-FITC To estimate haematopoietic progenitors present in the transmicrobeads (Miltenyi Biotec, Auburn, CA, USA) was perplant, 10 5 fetal liver cells were cultured per 30 mm dish in formed according to the instructions of the manufacturer semi-solid medium (0.8% methylcellulose) essentially on positive selection columns. Flow cytometric analysis according to Merchav and Wagenmaker 15 with addition of performed on splenocytes before and after B cell separation 10% heat-inactivated fetal calf serum (Sera-Lab, Crawley revealed that the positively selected cells consisted of 75-Down, UK) and colony-stimulating factor 1 (CSF-1). Cells 92% (average 86%) of labelled B cells. The negatively were plated in triplicate. After 7 and 14 days, the number selected fraction contained less than 1% (average 0.6%) of CFU-C-derived progenitor colonies larger than 50 cells labelled B cells. Splenic T cells were then selected from was scored.
this negatively selected fraction after staining with FITCconjugated H129-19 (anti-CD4) and FITC-conjugated 53-6.7 (anti-CD8) simultaneously. Flow cytometric analysis Haematopoietic cell collection before and after magnetic T cell separation showed that the positively selected fraction contained 85-93% (average In order to examine the haematopoietic system of the transplanted animals, mice were anaesthetized with ether at 3, 90%) labelled T cells, whereas the negatively selected fraction still contained 9-40% (average 18%) labelled T cells. . cytes were performed in triplicate as described. 16 The cells AdoHcyase, which catalyses the hydrolysis of S-adenwere stimulated with lipopolysaccharide (LPS, 15 g/ml;
osyl-l-homocysteine (AdoHcy) to Ado and homocysteine, Difco Laboratories, Detroit, MI, USA) or concanavalin A is inhibited by Ado 22, 23 and inactivated by dAdo. 23, 24 (ConA, 6 g/ml; Pharmacia, Uppsala, Sweden) in the presIndeed, AdoHcyase activity was markedly reduced in the ence or absence of various concentrations of dAdo (Sigma, livers of day-14 ADA−/− embryos, being 11% of the St Louis, MO, USA). activity in livers of ADA+/+ and ADA+/− embryos (260 Ϯ 37 nmol/h/mg wet tissue, n = 6). PNP activity in Results the liver at day 14 of gestation was similar in all three genotypes (4462 Ϯ 697 nmol/h/mg wet tissue, n = 9).
Histology and ADA-associated metabolism of the day-14 ADA-deficient fetal liver
Haematopoietic progenitor content of day-14 ADADuring murine embryogenesis, totipotent haematopoietic deficient fetal livers stem cells originate in the yolk sac, then migrate to the fetal liver (at gestational day 10) and shortly before birth Two pregnant ADA+/− 129/Ola mice were sacrificed, after colonize the bone marrow.
20,21 Because ADA-deficient mating with ADA+/− 129/Ola males, at day 14-15 of gesmice die perinatally, we used day-14-15 ADA-deficient tation and the livers of all five embryos were isolated. fetal liver cells as a stem-cell source for the haematopoietic Direct zymogram analysis on remaining embryonic reconstitution of lethally irradiated syngeneic wild-type material revealed ADA activity in two of the five embryos. recipients.
These results were confirmed by Southern blot analysis: The liver of newborn ADA-deficient mice shows severe one embryo was genotypically ADA+/+ (male), one hepatocellular degeneration and increased extramedullary ADA+/− (male) and three were ADA−/− (all females). The haematopoiesis. 6, 7 Histological examination of day-14 ADA+/+ (6.3 × 10 7 cells) and ADA+/− (6.1 × 10 7 cells) ADA−/−, ADA+/− and ADA+/+ embryos showed no fetal livers contained 50% more nucleated cells than the abnormalities. However, the ADA-associated metabolic ADA−/− fetal livers (4.3 Ϯ 0.4 × 10 7 cells, n = 3). pathways in the day-14 fetal liver of ADA−/− embryos As a measure for haematopoietic function, in vitro were affected relative to ADA+/− and ADA+/+ embryos.
(colony-forming unit-culture, CFU-C) and in vivo (day-12 While ADA activity was 4664 Ϯ 586 nmol/h/mg wet tissue colony-forming unit-spleen, CFU-S) clonal assays were (n = 3) in ADA+/+ livers, it was absent in ADA−/− livers, performed for committed and early haematopoietic progenias expected. Due to the ADA deficiency, the ADA subtor cells, respectively. The number of CFU-C-derived prostrates Ado and dAdo had accumulated. In the livers of genitor colonies per 10 5 nucleated fetal liver cells was simi-ADA+/+ and ADA+/− day-14 embryos, levels of free Ado lar for ADA+/+ (n = 3), ADA+/− (n = 3) and ADA−/− and dAdo were barely detectable (Ͻ3.1 and Ͻ1.5 nmol/g embryos (n = 9) at 7 (82 Ϯ 24) and 14 days (122 Ϯ 19) of wet tissue), whereas they were elevated in ADA−/− culture. The day-12 spleen colony-forming efficiency was embryos to 47.4 nmol (Figure 1a 
Long-term haematopoietic reconstitution following ADAdeficient fetal-liver cell transplantation
The survival and repopulation of lethally irradiated mice transplanted with ADA-deficient fetal liver cells was investigated. In total, 18 mice were transplanted with 10 7 fetal liver cells each: four, four and ten mice received an ADA+/+, ADA+/− and ADA−/− FLT, respectively. One ADA+/− fetal liver chimaera died 6 months after transplantation of unknown causes. The remaining mice were sacri- ficed at various time-points during the experiment, up to In humans, engraftment after bone marrow transplantation for ADA deficiency is characterized by chimaerism for cir-= 4) of ADA+/+ cells in the spleen (see also Figure 3c ). culating lymphocytes. T cells are exclusively of donor origin, whereas B cells may continue to arise from host stem cells. 2 Since the percentages of endogenous repopulation measured in the spleen and peripheral blood of the ADA−/− fetal liver chimaeras (approximately 20%) are in the range of the percentages of T cells present within the nucleated cell population of the spleen (18-46%) and peripheral blood (12-66%), we tested the possibility that mature T cells in ADA−/− fetal liver chimaeras were selectively of recipient type. Separation of the T cells and B cells from the spleen at 13 months after FLT, revealed that the endogenous ADA+/+ cells were divided over B220-positive B cells (average 18%, range 11-22%, n = 4), CD4/CD8-positive T cells (35%, n = 5) and the remaining, B220/CD4/CD8-negative cells (32%, n = 5, Figure 3c ). Hence, stable mixed chimaeras were established. Moreover, 65% of T cells in the ADA−/− fetal liver chimaeras were of the ADA−/− phenotype. This, together with the observations that the relative frequencies (not shown) and the proliferative response to ConA (Figure 4a to ConA. This conclusion was sustained by activating thy- The 11.0-kb band is diagnostic for the wild-type ADA allele (wt), whereas the 9.5-kb band is diagnostic for the mutated ADA allele (mt). The intensity of the band diagnostic for the wild-type ADA allele relative to that for the mutated allele is depicted below each lane. A third, upper band is due to cross hybridization of the probe with unknown cellular sequences. physiological agent that is considered to cause cytotoxicity Discussion resulting in immunodeficiency in ADA-deficient humans. The ConA-induced proliferation of thymus cells from ADA-deficient mice die perinatally. 6 However, since the ADA−/− fetal liver chimaeras was inhibited to a similar absence of functional ADA affects primarily the haematoextent but at lower concentrations dAdo than the proliferpoietic system in both humans and mice postnatally, we ation of thymus cells from ADA+/+ fetal liver chimaeras investigated the feasibility of generating an animal model (Figure 4b Despite the 9.5-Gy total body irradiation, some endogenous repopulation was observed. Although 9.5-Gy total body irradiation proved lethal to 129/Ola mice, it apparently did not eradicate all endogenous haematopoietic stem cells. A more stringent radiation regimen excluding haematopoietic repopulation is likely to induce a lethal gastrointestinal syndrome. The endogenous repopulation observed in the thymus, spleen and peripheral blood of ADA−/− fetal liver chimaeras remained stable at approximately 20% and the endogenous, ADA+/+ cells were found among the various haematopoietic cell types.
Why are the ADA−/− fetal liver chimaeras not immunodeficient? The fact that ADA − SCID patients improve immunologically and clinically with enzyme substitution in the form of polyethylene-glycol modified bovine ADA (PEG-ADA) 27 ,28 suggests that in humans it is not necessary to restore ADA to the lymphoid tissue to restore lymphoid function. In culture, under non-toxic conditions, human ADA-deficient primary T cells can exert normal immunological functions. 29 If, indeed, the intrinsic production of ADA by lymphoid cells is not necessary, then the cell type phocytes from ADA-deficient patients receiving PEG-ADA. They observed that human ADA-deficient peripheral blood lymphocytes transplanted to immunodeficient mice maturation and to test treatment options, such as gene therapy.
did not survive in contrast to normal and human ADA genetransduced ADA-deficient peripheral blood lymphocytes. Compared with those of ADA+/− and ADA+/+ litter mates, the livers of day-14 ADA−/− embryos were histoAlthough these and similar results, obtained with established human ADA-deficient T cell lines in culture, 30 seem logically normal in contrast to those of ADA−/− newborn mice. 6, 7 Metabolically, however, they showed elevated conto suggest that without intracellular ADA cells cannot survive, the (extra)cellular ADA levels directly surrounding centrations of Ado, dAdo and adenine deoxyribonucleotides as do livers of newborn ADA−/− mice. The concenthe ADA-deficient cells in vitro and/or in vivo might not have been high enough. tration of dAdo was already high enough to cause an 89% system pathology of human adenosine deaminase deficiency.
Clearly, the apparently normal ADA−/− fetal liver chi- 
